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Herpes simplex virus type 1 (HSV-1) glycoprotein B (gB)
is virally encoded and embedded in the viral envelope and in
cell membranes of infected cells. The gB gene was sequenced, and the primary and secondary structures of the gB
protein were predicted (3, 17). gB is essential for the
production of infectious virus particles (6, 16). Analyses of
several mutant viruses showed that gB is essential in the
penetration of virions into host cells and virus-induced
membrane fusion of adjacent cells (3, 6, 9, 13, 15, 16, 21-23).
A mutation in gB causing extensive syncytium (syn) formation was mapped to the carboxy-terminal portion of gB (2,
13) which was predicted to lie in the cytoplasm (8, 17). This
mutation (syn3) is most probably an Arg-to-His change at
amino acid position 857 in the published HSV-1(KOS) protein sequence (2), which is amino acid position 828 in the
HSV-1(KOS) and HSV-1(F) mature proteins after cleavage
of the signal peptide (17). This amino acid change is located
near the carboxy terminus of a predicted 31-amino-acid
a-helical peptide segment (Fig. 1B). A second site in the
cytoplasmic portion of gB that when altered causes cell
fusion was identified between residues 816 and 817 in the
HSV-1(KOS) protein (4), which are residues 786 (glutamine)
and 787 (leucine) in the HSV-1(KOS) and HSV-1(F) mature
proteins (17). An elegant complementation system which
utilizes gB-null viruses and transfected gB genes was used to
map functional domains of gB (4-6). The carboxy-terminal
41-amino-acid segment of HSV-1 gB was shown to be
nonessential for production of infectious virus particles,
glycoprotein maturation, and virus-induced cell fusion (11).
We report here the development of a system which utilizes
simian virus 40-based expression vectors to complement
gB-null viruses and to create recombinant viruses specifying
altered gBs. We used this system to delineate carboxyterminal domains of gB involved in the production of infectious virus and cell fusion.
Construction of gB genes that specify carboxy-terminal
truncations. The syn3 mutation is located at the end of a
*
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predicted 31-amino-acid a helix (Fig. 1B). To examine the
role of this predicted a-helical domain of gB in virus-induced
cell fusion and virus growth, we constructed three amber
mutations in gB genes. Plasmid pRB2080 contains a 3,353-bp
HSV-1(F) DNA including the entire coding region of gB, 150
bp from the 5'-flanking sequence, and 493 bp from the
3'-flanking sequence (13). A SalI-BamHI DNA fragment
from pRB2080 containing the gB sequence was cloned into a
pUC19 plasmid (24) that was previously modified to carry a
BglII site within its polylinker, creating plasmid p2080.
Subsequently, gB was excised from p2080 with BglII and
BamHI and cloned into the BglII site of P90123, placing the
5' end of the gB gene proximal to the adenovirus late
promoter in P90123 (26) as explained for a similar construct
previously (18). Plasmid constructs p1511, p1528, and p1513
were constructed by insertion of the synthetic oligonucleotide linker SpeI* (CTAGACTAGTCTAG) that carries stop
codons in all three reading frames and the recognition
sequence for restriction enzyme SpeI into unique restriction
sites BstEII (p1511), NcoI (p1528), and NheI (p1513) of
p2080. Plasmid p1537 was created by an in-frame fusion of
clones pRB2024 and pRB2107 (13) resulting in an internal
truncation from amino acids 130 to 697. These modified gB
genes were then cloned into P90123 to produce plasmids
P9-1511, P9-1528, P9-1513, and P9-1537 as explained above
for p2080. The DNA sequence of each construct containing
the site of the SpeI* linker insertion was determined by
polymerase chain reaction (PCR)-assisted DNA sequencing
as described previously (12). Briefly, a 297-bp DNA fragment of gB was amplified by PCR using primers gBl (5'CTAACCACCAAGGAGCTCAAGAA-3') and gB2 (5'-AG
GTCGTCCTCGTCGGCGTCA-3'). PCRs were performed
with 2.5 U of Taq DNA polymerase (GIBCO-BRL, Gaithersburg, Md.) in 100-,ul reaction mixtures containing 0.01%
bovine serum albumin and 0.1% Tween 20 in 20 mM TrisHCl (pH 8.3), 25 mM KCl, 2 mM MgCl2, 200 ,uM (each)
deoxynucleoside triphosphates, and each primer at 0.2 ,uM.
The samples were overlaid with mineral oil and subjected to
22 cycles of 2 s at 98°C, 1 min at 66°C, and 2 min at 72°C in
a programmable DNA thermal cycler (Eppendorf, Fremont,
Calif.). Final extension was at 72°C for 5 min. Singlestranded DNA of the amplified gB DNA fragment was
2396
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Three amber mutations were introduced proximal to the syn3 locus of the herpes simplex virus type 1
glycoprotein B (gB) gene specifying gB derivatives lacking the carboxy-terminal 28, 49, or 64 amino acids. A
complementation system that utilized gBs expressed in COS cells to complement gB-null virus KAT was
established. The 49- or 64-amino-acid-truncated gBs failed to complement gB-null virus KAT, while the
28-amino-acid-truncated gB complemented KAT efficiently. Mutant herpes simplex virus type 1 KOS
(amblS11-7) specifying the 28-amino-acid-truncated gB fused Vero cells extensively.
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FIG. 1. (A) DNA and predicted amino acid sequences of a portion of the HSV-1(F) gB gene, ambl511-7, and plasmids P9-1511, P9-1513,
and P9-1528 from amino acids 804 to 848 (17). The corresponding portion of the published HSV-1(KOS) gB sequence is from amino acids 834
to 878 (3). The SpeI* insertions in amb1511-7, P9-1511, P9-1513, and P9-1528 are shown underneath the gB sequence, and the in-frame stop
codons are indicated. (B) A schematic representation of the predicted secondary structure of the cytoplasmic portion of glycoprotein B is
shown as described previously (17). The gB truncations in ambl and ambl511-7 mutant viruses, P9-1513, P9-1528, and the syn3 mutation are
indicated by arrows. The relevant predicted a helices are denoted as H17a and H17b and marked by dashed lines.
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FIG. 2. COS cells were transfected with plasmids P9-2080, P91511, P9-1528, P9-1513, and P9-1537 and labeled with 35S-methionine from 40 to 46 h posttransfection. COS cell lysates were
immunoprecipitated with anti-gB MAb HSB1. Immunoprecipitates
were electrophoresed in an SDS-10% polyacrylamide gel and visualized by autoradiography. Lanes: 1, P9-2080 gB; 2, P9-1511 gB; 3,
P9-1528 gB; 4, P9-1513 gB; 5, P9-1537 gB. Molecular mass standards
were phosphorylase b (94 kDa), bovine serum albumin (67 kDa),
ovalbumin (43 kDa), and carbonic anhydrase (30 kDa). The positions of the molecular mass standards were marked with radioactive
ink after the gel was stained with Coomassie blue.

produced by PCR using 10 ,ul of the amplified gB DNA and
primer gB2 at 0.2 ,uM. PCR parameters were 25 cycles of 3
s at 98°C, 1 min at 66°C, and 1.5 min at 72°C with a final
incubation at 72°C for 5 min. The best results were obtained
by using 5 to 10 pmol of primer gBl per reaction for dideoxy
DNA sequencing reactions (20).
The gB DNA sequence specifying the 45-amino-acid peptide segment from amino acids 804 to 848 of the HSV-1(F)
protein that contains the SpeI* linker insertions is shown in
Fig. 1A. The predicted secondary structure of the carboxyterminal portion of gB showing the locations of the truncations specified by P9-1511, P9-1513, and P9-1528 as well as
the locations of other relevant mutations is shown in Fig. 1B.
P9-1511, P9-1513, and P9-1528 are predicted to specify
carboxy-terminal truncations of 28, 49, and 64 amino acids,
respectively. In P9-1511, the insertion of the SpeI* linker
produced an in-frame stop codon. Insertion of the SpeI*
linker in P9-1513 added two amino acids (Leu and Asp)
before encountering a stop codon. Similarly, an additional
Ile was added in P9-1528 (Fig. 1A).
Expression of gB genes in COS cells. COS cells were
transfected with gB gene constructs cloned into P90123 by
the calcium phosphate method (7, 10). Transfected cells

298-

FIG. 3. Photograph of an ethidium bromide-stained agarose gel
in which each PCR DNA fragment obtained with primers gBl and
gB2 was digested with SpeI and electrophoretically separated. Lane
1, k phage DNA 1-kbp ladder (BRL); lanes 2, 3, 4, 5, and 6, PCR
DNA fragments restricted with SpeI from KOS and ambl511-4, -7,
-9, and -19 viral DNAs, respectively.

were labeled with 35S-methionine from 40 to 46 h posttransfection. Proteins were extracted from transfected cells with
1% Nonidet P-40 and 0.5% sodium deoxycholate in extraction buffer (50 mM Tris buffer, 50 mM NaCl, 100 ,ug of
phenylmethylsulfonyl fluoride per ml, 1 ,ug of aprotinin per
ml, pH 7.5) and immunoprecipitated as described previously
(18). Samples were electrophoresed in sodium dodecyl sulfate (SDS)-polyacrylamide gels (14, 19). Monoclonal antibody (MAb) HSB1 was produced in this laboratory by
following standard procedures (1). HSB1 precipitated gB
from cellular extracts of HSV-1(KOS)-infected Vero cells
and COS cells in a manner similar to that of MAb H126 (18,
19). A comparison of the reactivities of MAbs HSB1 and
H126 is shown in Fig. 5. Because of the availability of larger
amounts of MAb HSB1, it was used throughout these
experiments. Radioimmunoprecipitates of gB expressed in
COS cells are shown in Fig. 2. P9-2080 specified gB migrating with an apparent molecular mass of approximately 115
kDa, determined by comparison with the molecular mass
standards described in the legend to Fig. 2. P9-1511, P91528, and P9-1513 expressed two forms of gB. The fastermigrating gB form produced by each gB construct represented most probably the high-mannose precursor form of
gB, since it comigrated with gB radiolabeled during a 30-min
labeling pulse (not shown). As expected, gB was not detected in P9-1537-transfected COS cells.
Isolation of virus recombinants. To isolate viruses that
specify the truncated gB derivatives, COS cells were
cotransfected with intact plasmids P9-1511, P9-1513, P91528, and P9-2080 (15 ,ug each per 25-cm2 flask) and intact
wild-type HSV-1(KOS) viral DNA (1 ,ug per flask). Viral
DNA was prepared by centrifugation of infected-cell lysates
in NaI density gradients (25). Progeny viruses were harvested 72 h postinfection (hpi) and used to infect confluent
monolayers of Vero cells. Individual, well-separated viral
plaques were examined by phase-contrast microscopy at 24
to 48 hpi. With the exception of virus stocks from cotransfections with P9-1511, all other cotransfections produced
virus plaques that were indistinguishable from wild-type
KOS plaques. Viruses obtained from cotransfections of
wild-type KOS viral DNA with P9-1511 reproducibly re-
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FIG. 4. Phase-contrast photomicrographs (magnification, x 125) of KOS (A), tsB5 (B) and amblS11-7 (C) virus-infected Vero cells
observed at 24 hpi.
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sulted in approximately 5% syncytial plaques in Vero cells
but not in HEp-2 cells (data not shown).
Several syncytial plaques from cotransfections of intact
KOS viral DNA and P9-1511 were isolated and plaque
purified three times. Viral DNAs from each virus plaque
were subjected to PCR analysis using primers gBl and gB2,
and PCR products were digested with restriction endonuclease SpeL. The resultant DNA fragments were visualized after
electrophoresis in a 1.5% agarose gel followed by ethidium
bromide staining (Fig. 3). Digestion of the 297-bp DNA
fragments obtained from syncytial amb4, amb7, amb9, and
ambl9 mutants with SpeI resulted in faster-migrating DNA
species, indicating that these DNA fragments contained an
SpeI site. In contrast, digestion with SpeI of the 297-bp
fragment derived from KOS viral DNA did not result in
faster-migrating DNA species (Fig. 3). The presence of the
SpeI* linker was confirmed by DNA sequencing of the
PCR-amplified 297-bp DNA fragments. No other mutation
was found within the PCR-amplified 297-bp DNA fragments.
A gB DNA segment containing the SpeI* linker from mutant
ambl511-7 virus is shown in Fig. 1A. Additional DNA
sequencing of approximately the terminal one-third of the
entire gB gene of the ambl511-7 virus revealed no other
mutations.
Cell fusion caused by ambl511-7. Confluent monolayers of
Vero cells were infected with the KOS, tsB5, and ambl511-7
strains at a multiplicity of infection of 5, and the cell cultures
were examined by phase-contrast microscopy and photographed at 24 hpi. The ambl511-7 strain fused Vero cells
extensively (Fig. 4) but failed to fuse HEp-2 cells (not
shown).
Synthesis of gB specified by mutant amblS11-7. Vero cell
monolayers were infected with HSV-1(KOS), the tsB5
strain, or the ambl511-7 strain at a multiplicity of infection
of 5 and labeled with 50 ,Ci of 35S-methionine per ml from 6
to 24 hpi. Infected cells were harvested by scraping with a
rubber policeman and were washed two times in phosphatebuffered saline. Immunoprecipitates from KOS, tsB5, and
amblS11-7 strain-infected cellular extracts with MAb HSB1
or H126 revealed the presence of gB migrating with an
apparent molecular mass of approximately 115 kDa (Fig. 5).
In addition, two gB-related peptides of 49 and 44 kDa were
precipitated. Cell surface expression of gB was tested by
immunofluorescence assay and fluorescence-activated cell
sorting analysis. amblS11-7 strain-infected cells expressed
gB that was transported to the cell surface in amounts similar
to the amount of gB synthesized in KOS-infected cells (not
shown).
Complementation of gB-null virus KAT by COS cells transfected with gB genes. gB-null virus KAT replicates in D6 cells
but not Vero cells. To ascertain whether gB constructs
cloned into expression vector P90123 under the control of
the adenovirus late promoter were able to complement KAT,
COS cells were transfected with the gB constructs and at 16
h posttransfection were infected with gB-null virus KAT.
Infected cells were collected at 24 hpi, and viral stocks were
prepared and their titers were determined on both Vero and
D6 cells. The results of these experiments are shown in
Table 1. Incorporation of a functional gB molecule (provided
by the transfected gB gene) into the KAT virion envelope
resulted in infectious virus particles that successfully infected D6 and Vero cells (complementation). Viral plaques
formed on D6 cells because these cells provided gB for
subsequent rounds of infectious virus particle production
required for plaque formation. Viruses that formed plaques
on Vero cells probably represent KAT rescued virus in
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FIG. 5. Vero cells were infected with KOS, tsB5, and ambl511-7
virus strains and labeled with 35S-methionine from 6 to 24 hpi. Cell
lysates were reacted with anti-gB MAb HSB1 or H126, and the
precipitates were electrophoretically separated in an SDS-10%
polyacrylamide gel. Lanes: M, molecular mass standards as described in the legend to Fig. 2; 1 and 2, HSV-1(KOS); 3 and 4, tsB5
virus; 5 and 6, amb1511-7 virus. Odd-numbered lanes, reactions
with MAb H126; even-numbered lanes, reactions with MAb HSB1.

which the truncation in the gB gene of KAT virus was
repaired through recombination with the transfected gB
gene. P9-1537 served as the negative control for these
experiments. This plasmid carries a large deletion in the gB
gene and cannot complement or rescue the KAT virus. Virus
stocks prepared from COS cells transfected with P9-1537
and superinfected with virus KAT did not produce any viral
plaques on either D6 or Vero cells. Virus stocks from
cultures transfected with P9-2080 and later superinfected
with virus KAT produced 5.2 x 103 virus plaques on D6 cells
and 4 plaques on Vero cells, indicating that gB specified by
P9-2080 complemented virus KAT. The small number of
viral plaques produced on Vero cells probably represented
KAT rescued viruses. Plasmid P9-1511 complemented KAT
virus as efficiently as P9-2080. In contrast, plasmids P9-1513,
TABLE 1. Complementation of HSV-1(KAT) by COS cells
transfected with gB genes
Transfected
plasmid

D6 cells

Growth (PFU/ml)a in:
Vero cells

4
103
8 (6 syn+ + 2 syn)
103
a COS cells were transfected with gB genes and infected with mutant KAT
16 h later. Virus stocks were prepared at 24 hpi. There was no growth in either
D6 or Vero cells transfected with P9-1513, P9-1528, or P9-1537.

P9-2080
P9-1511

5.2
2.4

x
x
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P9-1528, and P9-1537 failed to complement KAT (Table 1).
Virus stocks from P9-1511 transfections produced syn and
syn+ wild-type virus plaques on Vero cells. These viral
plaques were collected, and viral DNA was extracted and
tested for the presence of an SpeI* linker by restriction with
SpeI and DNA sequencing as explained earlier. Viral DNA
from syn viral isolates contained an SpeI* linker site within
the PCR-amplified gB DNA fragments. Viral DNAs from
syn+ viruses did not contain SpeI* linkers.
Conclusions. Transient expression vectors such as P90123
used in this study replicate to high numbers in COS cells,
allowing the expression and characterization of modified gB
proteins in the absence of any other viral proteins. We show
here for the first time that modified gB genes cloned into
P90123 can be used to efficiently complement gB-null virus
KAT and to isolate recombinant viruses.
It was reported that mutant ambl virus specifying a
41-amino-acid-truncated gB derivative replicated normally
in Vero cells, yielding titers similar to those yielded by the
wild-type virus strain HSV-1(KOS) (11). Similarly, we found
that the truncation of 28 amino acids of gB specified by
mutant amblS11-7 did not affect the ability of this virus to
replicate in cell culture. The 41-amino-acid gB truncation
specified by the ambl virus leaves the a-helical domain H17a
intact (Fig. 1B). We found that truncated gB derivatives of
49 and 64 amino acids failed to complement gB-null virus
KAT, and recombinant viruses specifying these truncations
could not be isolated. These truncations disrupt the ax-helical
domain H17a (Fig. 1B). Therefore, domain H17a may be
important for virus replication.
The ambl virus did not fuse Vero cells, although it
produced smaller plaques (11). We show here that the
28-amino-acid gB truncation specified by amblS11-7 caused
extensive cell fusion. This truncation eliminates half of a
predicted 14-amino-acid at helix (H17b) located immediately
after the 31-amino-acid a helix H17a (Fig. 1B) which may be
directly involved in the production of cell fusion. Alternatively, we favor the hypothesis that the 28-amino-acid truncation induces certain conformational changes in the cytoplasmic portion of gB that result in cell fusion. This implies
that the conformation of the cytoplasmic portion of gB may
be important in virus-induced cell fusion.
This research was supported by grant A127886 from the National
Institute of Allergy and Infectious Diseases to K.G.K.
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